<p>摩根大通分析師 Lisa Gill 維持了對 CI 股票的看漲態度，並在 5 月 13 日給予了買入評級。</p>
<h3>在 TipRanks 上享受 55% 的折扣</h3>
<ul>
<li>解鎖對沖基金級別的數據和強大的投資工具，以做出更聰明、更精準的決策</li>
<li>發現表現優異的股票投資理念，並升級到市場領先者的投資組合，使用智能投資者精選</li>
</ul>
<p>Lisa Gill 給予買入評級的原因是多種因素的結合，突顯了 Cigna 強大而靈活的資本狀況。該公司產生了可觀的自由現金流，不僅支持內部增長計劃，還通過分紅和股票回購向股東提供持續的資本回報，同時 Evernorth 正在過渡到無回扣的 PBM 模式。</p>
<p>Cigna 在收購 Express Scripts 後迅速降低了槓桿，目前的運營接近其長期債務資本目標，並得到了穩健的投資級評級的支持。管理層計劃以平衡的方式分配未來的現金流，強調穩定的分紅增長、持續的股票回購以及有紀律的、增值的併購，這為雙位數調整後每股收益的增長提供了強勁的前景，使得該股票在當前水平上具有吸引力。</p>
<p>在 5 月 13 日發佈的另一份報告中，美國銀行證券也重申了對該股票的買入評級，並設定了 378.00 美元的目標價。</p>

信諾保險

<p>摩根大通分析師 Lisa Gill 對信諾保險（Cigna，股票代碼：CI）維持了買入評級，原因是其強勁的自由現金流、降低的槓桿率以及對雙位數每股收益增長的積極展望。該公司的穩健資本狀況支持分紅和股票回購，同時管理層計劃進行平衡的現金流分配。美國銀行證券也重申了買入評級，目標價為 378 美元</p>

<p>J.P. Morgan analyst Lisa Gill has maintained their bullish stance on CI stock, giving a Buy rating on May 13.</p>
<div class="lb-trans"><p>摩根大通分析師 Lisa Gill 維持了對 CI 股票的看漲態度，並在 5 月 13 日給予了買入評級。</p>
</div><h3>Claim 55% Off TipRanks</h3>
<div class="lb-trans"><h3>在 TipRanks 上享受 55% 的折扣</h3>
</div><ul>
<li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions</li>
<li>Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks</li>
</ul>
<div class="lb-trans"><ul>
<li>解鎖對沖基金級別的數據和強大的投資工具，以做出更聰明、更精準的決策</li>
<li>發現表現優異的股票投資理念，並升級到市場領先者的投資組合，使用智能投資者精選</li>
</ul>
</div><p>Lisa Gill has given his Buy rating due to a combination of factors that highlight Cigna’s strong and flexible capital position. The company generates substantial free cash flow, which not only supports internal growth initiatives, but also enables consistent capital returns to shareholders through dividends and share repurchases while Evernorth transitions to a rebate‑free PBM model.</p>
<div class="lb-trans"><p>Lisa Gill 給予買入評級的原因是多種因素的結合，突顯了 Cigna 強大而靈活的資本狀況。該公司產生了可觀的自由現金流，不僅支持內部增長計劃，還通過分紅和股票回購向股東提供持續的資本回報，同時 Evernorth 正在過渡到無回扣的 PBM 模式。</p>
</div><p>Cigna has rapidly reduced leverage following the Express Scripts acquisition and now operates near its long‑term debt‑to‑capital target, supported by solid investment‑grade ratings. Management’s plan to allocate future cash flows in a balanced manner, emphasizing steady dividend growth, ongoing buybacks, and disciplined, accretive M&amp;A, underpins a robust outlook for double‑digit adjusted EPS growth, making the stock attractive at current levels.</p>
<div class="lb-trans"><p>Cigna 在收購 Express Scripts 後迅速降低了槓桿，目前的運營接近其長期債務資本目標，並得到了穩健的投資級評級的支持。管理層計劃以平衡的方式分配未來的現金流，強調穩定的分紅增長、持續的股票回購以及有紀律的、增值的併購，這為雙位數調整後每股收益的增長提供了強勁的前景，使得該股票在當前水平上具有吸引力。</p>
</div><p>In another report released on May 13, Bank of America Securities also reiterated a Buy rating on the stock with a $378.00 price target.</p>
<div class="lb-trans"><p>在 5 月 13 日發佈的另一份報告中，美國銀行證券也重申了對該股票的買入評級，並設定了 378.00 美元的目標價。</p>
</div>

Cigna Earns Buy Rating on Strong Free Cash Flow, Deleveraged Balance Sheet, and Double-Digit EPS Growth Outlook

- 摩根大通分析師 Lisa Gill 給予 Cigna 股票買入評級。  
- 她認為該公司資本狀況強勁，支持穩定分紅和股票回購。  
- 美國銀行證券也重申買入評級，並設定 378.00 美元目標價。

Tip Ranks

摩根大通

美國銀行

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

信諾保險因其強勁的自由現金流、資產負債表去槓桿化以及兩位數的每股收益增長預期而獲得買入評級